Expediting International Clinical Trials for Pivotal Products Key Participants Include International Long-Term and Healthcare Funds HONG KONG, Oct. 13, 2024 /PRNewswire/ — Akeso Biopharma (9926. HK) (“Akeso”, the “Company” ) announced that it has successfully raised approximately $250…